AzTrials
AzTrials

Adherence, MedicationYouthPrEPNCT03778892

Youth-focused Strategies to Promote Adherence to Pre-exposure Prophylaxis Among Youth At-risk for HIV in Thailand

A study testing 'Project Raincoat' Mobile Phone Application in people with Adherence, Medication and Adolescent Behavior, run by Chulalongkorn University at 1 site in Thailand.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A randomized controlled clinical trial looking at the effect of use of a mobile phone application in addition to standard care compared to standard care alone at a youth-friendly clinic in young men who have sex with men and transgender women aged between 15-19 years at risk of HIV on PrEP adherence. Read more about this study

Who is it for?
Ages 15 to 19 years, men onlyHealthy volunteers can take part
What is being tested?
'Project Raincoat' Mobile Phone Application
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteThailand
Study dates
1 Mar 2018to 15 Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 19 years
  • Men only
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Adolescent men who have sex with men
  • At high risk of HIV infection (have at least one of the following)
  • More than 1 sexual partner in the last 6 months
  • Irregular condom use during sexual intercourse
  • HIV positive sexual partner
  • Age 15 to under 20 years old
Show all 9Show fewer
  • A desire to take PrEP to prevent HIV infection
  • Tested HIV negative within 1 month of enrolment
  • Able to provide written consent or assent to take part in the clinical trial

Who cannot join

  • Signs or symptoms of acute retroviral syndrome that cannot be confirmed to be due to alternate causes, including unremitting fevers, headaches, myalgia, fatigue, and lymphadenopathy

Trial locations and contacts

1 site in 1 country.

Thailand1 site
  • Thai Red Cross AIDS Research Center

    Bangkok, 10330

Other trials in Thailand

About this study

A randomized controlled clinical trial looking at the effect of use of a mobile phone application in addition to standard care compared to standard care alone at a youth-friendly clinic in young men who have sex with men and transgender women aged between 15-19 years at risk of HIV on PrEP adherence.

Read the detailed description

OBJECTIVES

Primary Objectives:

To study PrEP adherence in adolescent MSM who are at high risk of HIV acquisition.

Secondary Objectives:

To study

  1. Rates of HIV infection
  2. Rates of sexually transmitted infections (STIs)
  3. Sexual risk taking behaviours In adolescent MSM who are at high risk of HIV infection.

HYPOTHESES:

  1. The investigators hypothesize that youth-focused interventions will produce superior adherence to PrEP from 50% with standard interventions to 70% with youth focused interventions.
  2. The investigators hypothesize that adherence to PrEP varies by the level of risk behavior one perceives. Participants who take higher risk behaviors will be more likely to adhere to PrEP than participants who have lower risk behaviors. STIs are expected to be more common among participants with higher levels of adherence if they are participants who have higher risk behaviors.

RESEARCH DESIGN:

Randomised control trial, behavioural intervention

RESEARCH METHODOLOGY

  1. Study population Volunteers aged 15 to under 20 years at high risk of HIV infection receiving PrEP under the 'Princess PrEP' project
  2. Inclusion Criteria
  • Adolescent men who have sex with men
  • At high risk of HIV infection (have at least one of the following)
  • More than 1 sexual partner in the last 6 months
  • Irregular condom use during sexual intercourse
  • HIV positive sexual partner
  • Age 15 to under 20 years old
  • A desire to take PrEP to prevent HIV infection
  • Tested HIV negative within 1 month of enrolment
  • Able to provide written consent or assent to take part in the clinical trial
  1. Exclusion criteria Signs or symptoms of acute retroviral syndrome that cannot be confirmed to be due to alternate causes, including unremitting fevers, headaches, myalgia, fatigue, and lymphadenopathy
  2. Study recruitment
  • Eligible persons presenting to the Thai Red Cross Anonymous Clinic (TRCARC) or its affiliated community based organizations (Rainbow Sky Association Thailand (RSAT) Ramkamhaeng, Sex Workers in Action Group (SWING) Bangkok will be asked by counsellors on their interest to join the study.
  • Number of participants to be studied: 200
  1. Informed consent process/ informed assent The research doctor will explain to potential participants about the purposes of the study and allow them to ask any questions they may have on it, and will be given time to make their decision. If a participant chooses to join the study, they will be asked for their written consent/assent and a copy of the informed consent/assent form given to them.
  • Participants aged between 15 and 18 will be asked for assent. As this is a study on sexual health where disease prevention is of utmost concern, parental consent will not be asked for.
  • Participants aged 18 to 19 will be asked for consent.
  1. Study procedure After informed consent or assent, all youth will commence once daily TFV/FTC 200/300mg. Volunteers will be randomized into arms 1 (standard intervention) or 2 (novel intervention strategy). Both groups will receive youth-focused counselling by trained counsellors and have access to an adolescent-friendly sexual health promotion website and social media page where they can get in contact with counsellors, doctors, fellow adolescents and function as a platform through which they can learn about good sexual health practices. Adolescents in arm 2 (novel intervention strategy) will also receive access to a mobile phone application.

Youth-focused counselling Counsellors will provide counselling that is friendly, non-judgmental and utilize motivational interviewing techniques where sessions are more collaborative rather than didactic.

Mobile Phone Application

  • Password protection will ensure user privacy
  • Will allow users to input weekly data on their:
  • Sexual risk e.g. no sexual activity, sex with condoms, sex without condoms
  • PrEP use e.g. whether or not participants take their PrEP
  • The application will calculate a percentage of protection users have based on their data entry
  • Points can be accumulated for application use, data input to the application, for attending appointments and also for normal STI and HIV screening results. Points can be redeemed for cash
  • The overall goal of the application is to increase participant awareness of self-risk and motivation to protect themselves against HIV and STI infection

Participants will be followed up at months 1, 3 and 6. At each visit, participants will complete a questionnaire on drug adherence and sexual health risk behaviours.

STI testing will be done as an indirect marker of condom use at visits 1 and 6. This will involve blood testing for syphilis serology and nucleic acid amplification testing for gonorrhea, and chlamydia on swab samples.

HIV testing will be done at all visits. TFV-DP DBS will be done at months 1, 3 and 6 to look at correlation of self-reported and actual measured PrEP compliance.

Drug Concentrations will be measured using the TFV-DP DBS at the Program for HIV Prevention and Treatment (PHPT), Chiang Mai. TFV-DP DBS levels ≥ 700 fmol/punch will be taken as adherence

Being tested
'Project Raincoat' Mobile Phone Application
Keywords
PrEP adherence, Youth, Adolescents, MSM, HIV Prevention, Mobile Health
Medical subject headings
Medication Adherence, Adolescent Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 'Project Raincoat' Mobile Phone ApplicationBehavioural

    Mobile phone application with weekly input channels for PrEP use, condom use, number of sex partners and sex acts and a calculation of self-HIV risk feedback scoring. Scoring system for attendance of visits, normal blood tests and use of application. Points redeemable for cash. Optional alarm system to remind to take medications and attend visits.

Study groups in NCT03778892
Study groupRoleWhat they receive
Novel InterventionExperimentalUse of a mobile phone application to support PrEP adherence in addition to youth-friendly counselling and services
Receives: Behavioral: 'Project Raincoat' Mobile Phone Application
Standard InterventionNo interventionUse of a mobile phone application to support PrEP adherence in addition to youth-friendly counselling and services

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PrEP Adherence

    Self-Reported Adherence

    Measured: Weekly self-reported adherence for a period of 6 months following randomization

  2. PrEP Adherence at 3 months

    Measured Serum TDF-DP Level (from dried blood spots)

    Measured: Measured at month 3 (measure of 17 day half life of TDF-DP)

  3. PrEP Adherence at 6 months

    Measured Serum TDF-DP Level (from dried blood spots)

    Measured: Measured at month 6 (measure of 17 day half life of TDF-DP)

Secondary outcomes (8)
  1. HIV infection rates

    seroconversion rates whilst on PrEP during study

    Measured: duration of study (6 months)

  2. Rates of Urethral Neisseria gonorrhea

    Rates of Urethral Neisseria gonorrhea via Nucleic Acid Amplification Screening (NAAT) urine testing

    Measured: duration of study (6 months)

  3. Behaviour Risk-Taking

    Composite calculated score of risk taking based on self-reported condom use, PrEP tablets taking, number of sexual partners in preceding one month. Scores will equate to risk levels of low, medium, high and very high.

    Measured: duration of study (6 months)

  4. Rates of Anal Neisseria gonorrhea

    Rates of Anal Neisseria gonorrhea via Nucleic Acid Amplification Screening (NAAT) from anal swab samples

    Measured: duration of study (6 months)

  5. Rates of Urethral Chlamydia trachomatis

    Rates of Urethral Chlamydia trachomatis via Nucleic Acid Amplification Screening (NAAT) urine testing

    Measured: duration of study (6 months)

  6. Rates of Anal Chlamydia trachomatis

    Rates of Anal Chlamydia trachomatis via Nucleic Acid Amplification Screening (NAAT) from anal swab samples

    Measured: duration of study (6 months)

  7. Rates of Syphilis Infection

    Rates of positive treponemal blood tests

    Measured: duration of study (6 months)

  8. Rates of Hepatitis B infection

    Rates of positive HbsAg blood tests

    Measured: At initial project visit (month 0)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Dec 2018
  2. Study start1 Mar 2018
  3. Primary completion15 Dec 2019
  4. Study completion15 Dec 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
half of study participants will receive the intervention
Masking
None (open label)
Enrolment
200 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03778892
Sponsor's protocol ID
2017/472-SON
Acronym
YouthPrEP
Status last verified
Jan 2020
First submitted
8 Dec 2018
Last updated
23 Jan 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Kawichai S, Songtaweesin WN, Wongharn P, Phanuphak N, Cressey TR, Moonwong J, Vasinonta A, Saisaengjan C, Chinbunchorn T, Puthanakit T. A Mobile Phone App to Support Adherence to Daily HIV Pre-exposure Prophylaxis Engagement Among Young Men Who Have Sex With Men and Transgender Women Aged 15 to 19 Years in Thailand: Pilot Randomized Controlled Trial. JMIR Mhealth Uhealth. 2022 Apr 21;10(4):e25561. doi: 10.2196/25561.

    PubMed 35451976
  • Songtaweesin WN, Kawichai S, Phanuphak N, Cressey TR, Wongharn P, Saisaengjan C, Chinbunchorn T, Janyam S, Linjongrat D, Puthanakit T; CE-PID - TRC Adolescent Study Team. Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trial. J Int AIDS Soc. 2020 Sep;23 Suppl 5(Suppl 5):e25564. doi: 10.1002/jia2.25564.

    PubMed 32869511

Questions about this trial

What is this clinical trial studying?

A study testing 'Project Raincoat' Mobile Phone Application in people with Adherence, Medication and Adolescent Behavior, run by Chulalongkorn University at 1 site in Thailand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PrEP Adherence (time frame: Weekly self-reported adherence for a period of 6 months following randomization). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03778892, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in